Evidence map›Paper›PMID 28555109›Full record

ArticleFrontiers in pharmacology2017

Rethinking the Appraisal and Approval of Drugs for Fracture Prevention.

Juan Erviti, Javier Gorricho, Luis C Saiz, Thomas Perry, James M Wright

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 2 pooled it
2.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 2 syntheses or guidelines pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. "Drugs to avoid" to improve quality use of medicines: how is Australia faring?Journal of pharmaceutical policy and practice · 2021
    Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Juan ErvitiUnit of Drug Assessment, Advice and Research, Navarre Regional Health ServicePamplona, Spain.
Javier GorrichoPlanning, Evaluation and Management Service, Health DepartmentPamplona, Spain.
Luis C SaizUnit of Drug Assessment, Advice and Research, Navarre Regional Health ServicePamplona, Spain.
Thomas PerryDepartment of Anaesthesiology, Pharmacology and Therapeutics, University of British ColumbiaVancouver, BC, Canada.
James M WrightDepartment of Anaesthesiology, Pharmacology and Therapeutics, University of British ColumbiaVancouver, BC, Canada.
Navarre Institute of Health Research · ESUniversity of British Columbia · CAMadrid Health Service · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

bisphosphonatescalcitoninsdenosumabdrug regulationhormone replacement therapyosteoporosis drugsstrontium ranelateteriparatide

Identifiers

PMID28555109
PMCPMC5430022
OpenAlexW2614077795

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.